Buy Granules India, price target Rs 140: Shrikant Chouhan
The analyst suggested a stop loss at Rs 129.

Granules India Ltd., incorporated in the year 1991, is a Mid Cap company (having a market cap of Rs 3411.88 Crore) operating in Pharmaceuticals sector.
Granules India Ltd. key Products/Revenue Segments include Pharmaceuticals which contributed Rs 2053.59 Crore to Sales Value (97.86 % of Total Sales) and Other Operating Revenue which contributed Rs 44.84 Crore to Sales Value (2.13 % of Total Sales) for the year ending 31-Mar-2019.
For the quarter ended 30-09-2019, the company has reported a Consolidated sales of Rs 699.53 Crore, up 17.51 % from last quarter sales of Rs 595.27 Crore and up 20.43 % from last year same quarter sales of Rs 580.87 Crore. Company has reported net profit after tax of Rs 95.79 Crore in latest quarter.
Download ET Markets APP